University of Wisconsin–Madison

Open Label Study to Evaluate the Safety of Copaxone and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated with Copaxone

The PI of this project is: Christopher Luzzio MD

This project is funded by: TEVA Pharmaceuticals

The term of this project is: July 2012 to January 2013

The number of subjects scanned during this project is: 5